Studies indicate antipsychotic dose reduction might improve recovery and function in young people with psychosis

invalid@example.com (schizosupport), schizosupport
Wed, 18 Feb 2026 04:13:00 +0000
General Medication Discussion

Antipsychotic dose reduction in young people with stable, first-episode psychosis may improve long-term functional recovery, cognitive function, and quality of life compared to standard maintenance, despite a higher initial risk of relapse. Studies indicate that lowering doses, such as in the REDUCE study, helps minimize side effects and supports better vocational and social outcomes, with long-term relapse rates becoming comparable to maintenance groups.

Key Findings on Dose...